晚期肾透明细胞癌一线靶向治疗的优化选择中国专家共识(2022)

2022-05-06 中国抗癌协会泌尿男生殖系肿瘤专业委员会肾癌学组 临床泌尿外科杂志

肾细胞癌简称肾癌(renal cell carcinoma, RCC)是起源于肾小管上皮的恶性肿瘤,约占肾脏恶性肿瘤的90%,其中最常见的组织类型为肾透明细胞癌(clear cell renal ce

中文标题:

晚期肾透明细胞癌一线靶向治疗的优化选择中国专家共识(2022)

发布日期:

2022-05-06

简要介绍:

肾细胞癌简称肾癌(renal cell carcinoma, RCC)是起源于肾小管上皮的恶性肿瘤,约占肾脏恶性肿瘤的90%,其中最常见的组织类型为肾透明细胞癌(clear cell renal cell carcinoma, ccRCC)[1]。临床使用最广泛的RCC分期系统是美国癌症分期联合委员会(American Joint Committee on Cancer Staging, AJCC)制定的TNM分期系统。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=晚期肾透明细胞癌一线靶向治疗的优化选择中国专家共识(2022).pdf)] GetToolGuiderByIdResponse(projectId=1, id=97f281c002a32584, title=晚期肾透明细胞癌一线靶向治疗的优化选择中国专家共识(2022), enTitle=, guiderFrom=临床泌尿外科杂志, authorId=0, author=, summary=肾细胞癌简称肾癌(renal cell carcinoma, RCC)是起源于肾小管上皮的恶性肿瘤,约占肾脏恶性肿瘤的90%,其中最常见的组织类型为肾透明细胞癌(clear cell renal ce, cover=https://img.medsci.cn/20220508/1652020392515_5579292.jpg, journalId=0, articlesId=null, associationId=2694, associationName=中国抗癌协会泌尿男生殖系肿瘤专业委员会肾癌学组, associationIntro=中国抗癌协会泌尿男生殖系肿瘤专业委员会肾癌学组, copyright=0, guiderPublishedTime=Fri May 06 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">肾细胞癌简称肾癌(renal cell carcinoma, RCC)是起源于肾小管上皮的恶性肿瘤,约占肾脏恶性肿瘤的90%,其中最常见的组织类型为肾透明细胞癌(clear cell renal cell carcinoma, ccRCC)[1]。临床使用最广泛的RCC分期系统是美国癌症分期联合委员会(American Joint Committee on Cancer Staging, AJCC)制定的TNM分期系统。&nbsp;</span></p>, tagList=[TagDto(tagId=330, tagName=肾癌), TagDto(tagId=5730, tagName=肾透明细胞癌), TagDto(tagId=117298, tagName=泌尿生殖系肿瘤), TagDto(tagId=437668, tagName=一线靶向治疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=23058, appHits=116, showAppHits=0, pcHits=473, showPcHits=22931, likes=0, shares=18, comments=1, approvalStatus=1, publishedTime=Mon May 09 15:28:00 CST 2022, publishedTimeString=2022-05-06, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sun May 08 22:35:52 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 11:38:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=晚期肾透明细胞癌一线靶向治疗的优化选择中国专家共识(2022).pdf)])
晚期肾透明细胞癌一线靶向治疗的优化选择中国专家共识(2022).pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1226714, encodeId=c1871226e14e9, content=怎么获得积分下载呢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00d32061099, createdName=1391edf56em, createdTime=Thu Jun 16 02:55:41 CST 2022, time=2022-06-16, status=1, ipAttribution=)]
    2022-06-16 1391edf56em

    怎么获得积分下载呢

    0